Phloretin Protects Macrophages from E. coli-Induced Inflammation through the TLR4 Signaling Pathway
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Macrophages are the cells of the first-line defense system, which protect the body from foreign invaders such as bacteria. However, Gram-negative bacteria have always been the major challenge for macrophages due to the presence of lipopolysaccharides on their outer cell membrane. In the present study, we evaluated the effect of phloretin, a flavonoid commonly found in apple, on the protection of macrophages from Escherichia coli infection. RAW 264.7 cells infected with standard E. coli, or virulent E. coli K1 strain were treated with phloretin in a dose-dependent manner to examine its efficacy in protection of macrophages. Our results revealed that phloretin treatment reduced the production of nitric oxide (NO) and generation of reactive oxygen species along with reducing the secretion of proinflammatory cytokines induced by the E. coli and E. coli K1 strains in a concentration-dependent manner. Additionally, treatment of phloretin downregulated the expression of E. coli-induced major inflammatory markers i.e. cyclooxygenase-2 (COX-2) and hemeoxygenase-1 (HO-1), in a concentration dependent manner. Moreover, the TLR4-mediated NF-κB pathway was activated in E. coli-infected macrophages but was potentially downregulated by phloretin at the transcriptional and translational levels. Collectively, our data suggest that phloretin treatment protects macrophages from infection of virulent E. coli K1 strain by downregulating the TLR4-mediated signaling pathway and inhibiting NO and cytokine production, eventually protecting macrophages from E. coli-induced inflammation.
Abstract
Macrophages are the cells of the first-line defense system, which protect the body from foreign invaders such as bacteria. However, Gram-negative bacteria have always been the major challenge for macrophages due to the presence of lipopolysaccharides on their outer cell membrane. In the present study, we evaluated the effect of phloretin, a flavonoid commonly found in apple, on the protection of macrophages from Escherichia coli infection. RAW 264.7 cells infected with standard E. coli, or virulent E. coli K1 strain were treated with phloretin in a dose-dependent manner to examine its efficacy in protection of macrophages. Our results revealed that phloretin treatment reduced the production of nitric oxide (NO) and generation of reactive oxygen species along with reducing the secretion of proinflammatory cytokines induced by the E. coli and E. coli K1 strains in a concentration-dependent manner. Additionally, treatment of phloretin downregulated the expression of E. coli-induced major inflammatory markers i.e. cyclooxygenase-2 (COX-2) and hemeoxygenase-1 (HO-1), in a concentration dependent manner. Moreover, the TLR4-mediated NF-κB pathway was activated in E. coli-infected macrophages but was potentially downregulated by phloretin at the transcriptional and translational levels. Collectively, our data suggest that phloretin treatment protects macrophages from infection of virulent E. coli K1 strain by downregulating the TLR4-mediated signaling pathway and inhibiting NO and cytokine production, eventually protecting macrophages from E. coli-induced inflammation.
참고문헌 (35)
- Nathan C, "Points of control in inflammation", Nature, 420, pp.846~852 (2002)
- Gabay C, "Interleukin-6 and chronic inflammation", Arthritis Res. Ther, 8, pp.1~6 (2006)
- Tasneem S, "Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents", Pharmacol. Res., 139, pp.126~140 (2019)
- Mankhong S, "4-Methoxycinnamyl p-coumarate isolated from Etlingera pavieana rhizomes inhibits inflammatory response via suppression of NF-κB, Akt and AP-1 signaling in LPSstimulated RAW 264. 7 macrophages", Phytomedicine, 54, pp.89~97 (2019)
- Hirayama D, "The phagocytic function of macrophage-enforcing innate immunity and tissue homeostasis", Int. J. Mol. Sci., 19, pp.E92~ (2017)
- Petersen HJ, "The role of the innate immune system in granulomatous disorders", Front. Immunol, 4, pp.120~ (2013)
- Ziauddin M, "Studies on immunomodulatory effects of Ashwagandha", J. Ethnopharmacol, 50, pp.69~76 (1996)
- Mariadoss AVA, "Pharmacological aspects and potential use of phloretin : A systemic review", Mini. Rev. Med. Chem, 19, pp.1060~1067 (2019)
- Tsao R, "Polyphenolic profiles in eight apple cultivars using high-performance liquid chromatography(HPLC)", J. Agric. Food Chem, 51, pp.6347~6353 (2003)
- Wei Y, "Molecular model and in vitro antioxidant activity of a water-soluble and stable phloretin", hydroxypropyl-β-cyclodextrin inclusion complex, 2017, pp.236, 68~75
- Huang WC, "Phloretin ameliorates chemokines and ICAM-1expression via blocking of the NF-κB pathway in the TNF-α-induced HaCaT human keratinocytes", Int. Immunopharmacol, 27, pp.32~37 (2015)
- Stangl V, "The flavonoid phloretin suppresses stimulated expression of endothelial adhesion molecules and reduces activation of human platelets", J. Nutr, 135, pp.172~178 (2005)
- Xu M, "Anticancer activity of phloretin against human gastric cancer cell lines involves apoptosis, cell cycle arrest, and inhibition of cell invasion and JNK signalling pathway", Med. Sci. Monit, 4, pp.6551~6558 (2018)
- Barreca D, "Biochemical and antimicrobial activity of phloretin and its glycosilated derivatives present in apple and kumquat", Food Chem, 160, pp.292~297 (2014)
- Cheon D, "Target proteins of phloretin for its anti-inflammatory and antibacterial activities against propionibacterium acnes-induced skin infection", Molecules, 24, pp.1319~ (2019)
- Kim J, "Phloretin as a potent natural TLR2", 1 inhibitor suppresses TLR2-induced inflammation, 2018, pp.10, 868~
- Lee JY, "Antimicrobial natural products as beta-ketoacyl-acyl carrier protein synthase III inhibitors", Bioorg. Med. Chem, 17, pp.5408~5413 (2009)
- Jeon D, "Phloretin exerts anti-tuberculosis activity and suppresses lung inflammation", Molecules, 22, pp.183~ (2017)
- Lee JH, "Apple flavonoid phloretin inhibits Escherichia coli O157 : H7 biofilm formation and ameliorates colon inflammation in rats", Infect. Immun, 79, pp.4819~4827 (2011)
- Jung M, "Influence of apple polyphenols on inflammatory gene expression", Mol. Nutr. Food Res, 53, pp.1263~1280 (2009)
- Mushtaq N, "Prevention and cure of systemic Escherichia coli K1 infection by modification of the bacterial phenotype", Antimicrob. Agents Chemother, 48, pp.1503~1508 (2004)
- Bateman SL, "Intracellular Macrophage Infections with E. coli under Nitrosative Stress", Bio Protoc., 2, pp.20~ (2012)
- Rallabhandi P, "Differential activation of human TLR4 by Escherichia coli and Shigella flexneri 2a lipopolysaccharide : combined effects of lipid A acylation state and TLR4 polymorphisms on signaling", J. Immunol, 180, pp.1139~1147 (2008)
- Vila J, "Escherichia coli : an old friend with new tidings", FEMS Microbiol. Rev, 40, pp.437~463 (2016)
- Mainil J, "Escherichia coli virulence factors", Vet. Immunol. Immunopathol, 152, pp.2~12 (2013)
- Sarowska J, "Virulence factors, prevalence and potential transmission of extraintestinal pathogenic Escherichia coli isolated from different sources : recent reports", Gut Pathog, 11, pp.10~ (2019)
- Bien J, "Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage", Int. J. Nephrol. (2012)
- Kim KS, "Human meningitis-associated Escherichia coli", EcoSal. Plus, 7 (2016)
- Glasser AL, "Adherent invasive Escherichia coli strains from patients with Crohn’s disease survive and replicate within macrophages without inducing host cell death", Infect. Immun, 69, pp.5529~55237 (2001)
- Mokady D, "Virulence factors of septicemic Escherichia coli strains", Int. J. Med. Microbiol, 295, pp.455~462 (2005)
- Sharma JN, "Role of nitric oxide in inflammatory diseases", Inflammopharmacology, 15, pp.252~259 (2007)
- Lee E, "Anti-inflammatory activities of cecropin A and its mechanism of action", Arch. Insect Biochem. Physiol., 87, pp.1~14 (2015)
- Zhang JM, "Cytokines, inflammation, and pain", Int. Anesthesiol. Clin, 45, pp.27~37 (2007)
- Kim J, "Development of a novel short 12-meric papiliocin-derived peptide that is effective against gram-negative sepsis", Sci. Rep., 9, pp.3817~ (2019)
- Lu YC, "LPS", TLR4 signal transduction pathway, 2008, pp.42, 145~151